Structure-based tailoring of compound libraries for high-throughput screening: discovery of novel EphB4 kinase inhibitors

High-throughput docking is a computational tool frequently used to discover small-molecule inhibitors of enzymes or receptors of known three-dimensional structure. Because of the large number of molecules in chemical libraries, automatic procedures to prune multimillion compound collections are useful for high-throughput docking and necessary for in vitro screening. Here, we propose an anchor-based library tailoring approach (termed ALTA) to focus a chemical library by docking and prioritizing molecular fragments according to their binding energy which includes continuum electrostatics solvation. In principle, ALTA does not require prior knowledge of known inhibitors, but receptor-based pharmacophore information (hydrogen bonds with the hinge region) is additionally used here to identify molecules with optimal anchor fragments for the ATP-binding site of the EphB4 receptor tyrosine kinase. The 21,418 molecules of the focused library (from an initial collection of about 730,000) are docked into EphB4 and ranked by force-field-based energy including electrostatic solvation. Among the 43 compounds tested in vitro, eight molecules originating from two different anchors show low-micromolar activity in a fluorescence-based enzymatic assay. Four of them are active in a cell-based assay and are potential anti-angiogenic compounds.     

Four New Nanaomycins Produced by Streptomyces hebeiensis Derived from Lichen

Four new nanaomycins ( 1  –  4 ), together with two known compounds, nanaomycin αA ( 5 ) and nanaomycin βA ( 6 ) were isolated from a fermentation broth of Streptomyces hebeiensis derived from lichen. The structures of the new nanaomycins 1  –  4 were established using comprehensive NMR spectroscopic data analysis as well as UV, IR, and MS data. The antimicrobial activities of 1  –  6 were evaluated against Gram‐positive bacteria and fungus. Compounds 5 and 6 showed antimicrobial activities against the test microorganisms, while 1  –  4 were inactive at 100 μg/ml.     

miR-10a Regulates Proliferation of Human Cardiomyocyte Progenitor Cells by Targeting GATA6

microRNAs (miRNAs) play essential roles in cardiogenesis. The altered expression of miRNAs can result in cardiac malformations by inducing abnormalities in the behavior of cardiac cells. However, the role of miR-10a in the regulation of cardiomyocyte progenitor cells (CMPCs) remains undetermined. In the present study, we found that up- or down-regulation of miR-10a inhibited or promoted the proliferation of human CMPCs, respectively, without affecting their differentiation toward cardiomyocytes. miR-10a bound to GATA6 directly and reduced GATA6 expression. Over-expression of GATA6 greatly attenuated the miR-10a-mediated inhibitory effect on the proliferation of human CMPCs. Thus, our results indicate that miR-10a could effectively modulate the proliferation of human CMPCs by targeting GATA6. The finding provides novel insights into the potency of miR-10a during heart development.     

伯克霍尔德氏菌ZYB002脂肪酶lipC24基因的克隆、表达及其酶学性质

【目的】克隆伯克霍尔德菌ZYB002菌株中的新型脂肪酶lip C24基因,测定其基本酶学性质,为后续深入研究该基因在菌株中的生理功能奠定基础。【方法】根据洋葱伯克霍尔德菌JK321菌株的全基因组DNA信息,直接设计引物从伯克霍尔德菌ZYB002菌株基因组中扩增出lip C24基因,并对之进行原核表达、重组蛋白的纯化及酶学性质分析。【结果】lip C24基因全长1317 bp,编码438个氨基酸残基;多肽链中具有保守五肽-G-X1-S-X2-G-序列;重组蛋白Lip C24的分子量为45 k Da;能有效水解各种对硝基苯酯,对中链脂肪酸的对硝基苯酯表现出偏爱性;其催化水解反应的最适温度为40℃,最适p H7.5;40℃下的半衰期为15.72 min,在p H 7.0-8.0的条件下,具有较好的稳定性。【结论】lip C24的编码产物为一个45 k Da蛋白,具有明显的脂肪酶活性,为中温中性脂肪酶。     

一株解磷细菌的筛选、鉴定及其溶磷培养条件的优化

从土壤作物根际筛选分离出的一株解磷能力较强的溶磷菌P0417,对其进行16S r DNA基因水平上的初步鉴定,测定其溶解磷的能力,并对该菌的溶磷培养基条件进行优化。结果表明,经序列分析,确定该菌株P0417为洋葱伯克霍尔德氏菌。且其溶磷能力与培养液p H呈显著相关性,当培养基条件为葡萄糖10 g/L、草酸铵0.5 g/L、Na Cl 1.0 g/L时,菌株P0417对Ca3(PO4)2盐培养基具有较好的解磷能力,其解磷能力可达791.84μg/m L。     

2000年间野生稻和栽培稻(O.sativa.L)分布区逆向分离的过程及动力Ⅰ.古今野生稻和栽培稻(O.sativa.L)的分布与人口分布的关系

２０００ａ间,中国境内野生稻分布区域由２４９５５７５ｋｍ２缩减至１３７１０９４ｋｍ２,减少了４５．０６％;分布纬度北界由３８°３′Ｎ南移至２８°１４′Ｎ,南移９°４９′、１１４０ｋｍ;中国境内栽培稻分布区域由４０８１８６０ｋｍ２增加至９６０００００ｋｍ２,增加了１３５．００％;分布北界由３８°Ｎ北移至５３°２９′Ｎ,北移１５°２９′、１７００ｋｍ。人口分布重心主要在黄河流域和长江流域,对该区域野生稻的生存产生不利影响。而促进栽培稻的发展,必须建立野生稻自然保护区。     

Novel A14841G mutation is associated with high penetrance of LHON/C4171A family

We report the clinical and genetic characterization of a Chinese LHON family carrying an ND1/C4171A mutation. This family has high penetrance of visual impairment and extremely low frequency of vision recovery, which is in marked contrast to previously reported results for Korean LHON families with the same mutation. Sequence analysis of the complete mtDNA in the partially defined East Asian haplogroup N9a1 revealed the presence of 29 other variants. A novel heteroplasmic A14841G mutation, one of the variants with a serine substituted for a highly conserved asparagine at amino acid 32 of Cytochrome b (Cytb), may play a synergistic role with the C4171A mutation, leading to significantly different clinical manifestations of LHON among these families. The study further confirmed that C4171A was a rare primary LHON mutation, and the mtDNA background could also contribute to the clinical manifestation of the LHON/C4171A mutation.     

Fabrication of Tip-Dissolving Microneedles for Transdermal Drug Delivery of Meloxicam

Dissolving microneedles (MNs) offered a simple, minimally invasive method for meloxicam (MX) delivery to the skin. However, the fabrication of dissolving MNs still faced some challenges, such as significant time consumption, loss of drug activity, and difficulty in regulating MN drug loading. To address these issues, we developed the tip-dissolving (TD) MNs. Several kinds of drugs were encapsulated successfully, and the quantity of MX ranged from 37.23?±?8.40 to 332.53?±?13.37 μg was precisely controlled. The effects of fabrication process on biomacromolecules stability were studied, and it was found that tyrosinase kept 90.4% activity during the fabrication process. The whole process for the fabrication of MNs only takes approximately 1 h. In order to further evaluate the potential of the TD MNs, MX TD MNs were prepared for in vitro release experiments, in vivo release experiments, safety evaluation, pharmacokinetic studies, and pharmacodynamic studies. The results demonstrated that MX TD MNs offered several advantages, including rapid release of the encapsulated drug (91.72% within 30 min), efficient drug delivery to skin (79.18%), no obvious skin irritation, decent relative bioavailability (122.3%), and strong anti-inflammatory and analgesic effects. Based on these results, we envisage that the TD MNs have promising potential for transdermal drug delivery of MX.     

A recombinant trans-membrane protein hMnSOD–R9 inhibits the proliferation of cervical cancer cells in vitro

Human manganese superoxide dismutase (hMnSOD) is a new type of cancer suppressor. Nonamer of arginine (R9) is an efficient protein transduction domain (PTD). The aim of the study was to improve the transduction efficiency of hMnSOD and investigate its activity in vitro. In this study, we designed, constructed, expressed, and purified a novel fusion protein containing the hMnSOD domain and R9 PTD (hMnSOD–R9). The DNA damaged by Fenton’s reagent was found to be significantly reduced when treated with hMnSOD–R9. hMnSOD–R9 fusion protein was successfully delivered into HeLa cells. The MTT assay showed that proliferation of various cancer cell lines were inhibited by hMnSOD–R9 in a dose-dependent manner. In addition, the cell cycle of HeLa cells was arrested at the sub-G0 phase by hMnSOD–R9. hMnSOD–R9 induced apoptosis of HeLa cells in a dose-dependent manner. With hMnSOD–R9 treatment, Bax, JNK, TBK1 gene expression was increased and STAT3 gene expression was gradually down-regulated in HeLa cells. We also found that apoptosis was induced by hMnSOD–R9 in HeLa cells via up-regulation of cleaved caspase-3 and down-regulation phospho-STAT3 pathway. These results indicated that hMnSOD–R9 may provide benefits to cervical cancer treatment.